相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of metformin on prostate cancer outcomes after radical prostatectomy
Dharam. Kaushik et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
Initial metformin or sulphonylurea exposure and cancer occurrence among patients with type 2 diabetes mellitus
H. Qiu et al.
DIABETES OBESITY & METABOLISM (2013)
Metformin and Prostate Cancer: Reduced Development of Castration-resistant Disease and Prostate Cancer Mortality
Daniel E. Spratt et al.
EUROPEAN UROLOGY (2013)
The Time Is Ripe for a Randomized Trial of Metformin in Clinically Localized Prostate Cancer
Kathryn L. Penney et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Metformin Use and All-Cause and Prostate Cancer-Specific Mortality Among Men With Diabetes
David Margel et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Association Between Metformin Use and Risk of Prostate Cancer and Its Grade
David Margel et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review
Monica Franciosi et al.
PLOS ONE (2013)
Lower Risk of Cancer in Patients on Metformin in Comparison With Those on Sulfonylurea Derivatives Results from a large population-based follow-up study
Rikje Ruiter et al.
DIABETES CARE (2012)
Mortality After Incident Cancer in People With and Without Type 2 Diabetes Impact of metformin on survival
Craig J. Currie et al.
DIABETES CARE (2012)
Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data
T. P. van Staa et al.
DIABETOLOGIA (2012)
The Influence of Type 2 Diabetes and Glucose-Lowering Therapies on Cancer Risk in the Taiwanese
Ming-Chia Hsieh et al.
EXPERIMENTAL DIABETES RESEARCH (2012)
Metformin and cancer: new applications for an old drug
Taxiarchis V. Kourelis et al.
MEDICAL ONCOLOGY (2012)
Cancer Risk Associated with Use of Metformin and Sulfonylurea in Type 2 Diabetes: A Meta-Analysis
Davide Soranna et al.
ONCOLOGIST (2012)
Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis
Hiroshi Noto et al.
PLOS ONE (2012)
Dietary fiber intake and risk of breast cancer: a meta-analysis of prospective cohort studies
Jia-Yi Dong et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2011)
Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients
X. -X. He et al.
ANNALS OF ONCOLOGY (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Metformin and the Incidence of Prostate Cancer in Patients with Type 2 Diabetes
Laurent Azoulay et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Diabetes and Risk of Prostate Cancer A study using the National Health Insurance
Chin-Hsiao Tseng
DIABETES CARE (2011)
Cohort Study of Pioglitazone and Cancer Incidence in Patients With Diabetes
Assiamira Ferrara et al.
DIABETES CARE (2011)
Further Exploration of the Relationship Between Insulin Glargine and Incident Cancer A retrospective cohort study of older Medicare patients
Nancy E. Morden et al.
DIABETES CARE (2011)
Impact of Biochemical Recurrence in Prostate Cancer Among US Veterans
Edward M. Uchio et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
Andrea DeCensi et al.
CANCER PREVENTION RESEARCH (2010)
Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycaemia in Diabetes) clinical trials
P. D. Home et al.
DIABETOLOGIA (2010)
Clinical Outcomes After Radical Prostatectomy in Diabetic Patients Treated With Metformin
Trushar Patel et al.
UROLOGY (2010)
Metformin use and prostate cancer in Caucasian men: results from a population-based case-control study
Jonathan L. Wright et al.
CANCER CAUSES & CONTROL (2009)
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
C. J. Currie et al.
DIABETOLOGIA (2009)
Metformin: diamonds are forever
N. Papanas et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
Sao Jiralerspong et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Antidiabetic Medication and Prostate Cancer Risk: A population-based Case-Control Study
Teemu J. Murtola et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
I. Ben Sahra et al.
ONCOGENE (2008)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Bias and causal associations in observational research
DA Grimes et al.
LANCET (2002)
分享论文
